Anbio Biotechnology (NNNN) Short-term Investments (2023 - 2025)
Anbio Biotechnology's quarterly Short-term Investments came in at $4.1 million in Q4 2025, up 126608.34% quarter-over-quarter from $3263.0 in Q4 2023.
Anbio Biotechnology has reported Short-term Investments for 2 years, with the latest figure at $4.1 million in Q4 2025.
- For the quarter ending Q4 2025, Short-term Investments changed N/A year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $4.1 million (changed N/A YoY), and the FY2025 full-year result was $4.1 million, changed N/A from the prior year.
- Short-term Investments for Q4 2025 stood at $4.1 million, up from $3263.0 in the prior quarter.
- The five-year high for Short-term Investments was $4.1 million in Q4 2025, with the low at $3263.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Anbio Biotechnology | 1.32 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.13 Mn |
| Jun 30, 2025 | 8,080.50 Bn |
| Dec 31, 2023 | 3,263.00 |